---
title: Alex Zhavoronkov
permalink: /alex-zhavoronkov/
variant: markdown
description: ""
image: /images/Speakers_AlexZhavaronkov.png
---
<div class="row">
<div class="col is-3">
<img src="/images/Speakers_AlexZhavoronkov.png">
</div>
<div class="col is-9 speaker-details">
	<h4><b>Dr Alex Zhavoronkov</b></h4>
<b>Founder and CEO<br>
	Insilico Medicine</b>
	
<p>Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine, a leading clinical-stage biotechnology company developing next-generation generative artificial intelligence and robotics platforms for drug discovery. Under his leadership, Insilico raised over $400 million in multiple rounds from expert biotechnology, healthcare, and financial investors, opened R&amp;D centers in 6 countries and regions, and partnered with multiple pharmaceutical, biotechnology, and academic institutions. Since 2021, the company nominated 18 preclinical candidates, started 6 human clinical trials, and entered Phase II with an AI-discovered novel target and AI-designed novel molecule. </p>
 <p>
Since 2012, he has published over 200 peer-reviewed research papers and 3 books. He is the adjunct professor of artificial intelligence at the Buck Institute for Research on Aging.
</p>
</div>
</div>